Primary Record
sulindac
- In stock
- 2,097 g
- Purity
- 99.8 %
- CAS
- 38194-50-2
Compound Identifiers & Properties
- CAS
- 38194-50-2
- PubChem CID
- 1548887
- SMILES
- CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
- Canonical SMILES
- CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1
Names & Synonyms
- sulindac
- Clinoril
- Arthrocine
- Sulindaco
- Artribid
- Sulindac sulfoxide
- Sulindacum
- Aflodac
- Citireuma
- Sulreuma
- Imbaral
- Mobilin
- Algocetil
- Arthrobid
- Clisundac
- Klinoril
- Reumofil
- 38194-50-2
- Sulinol
- Sudac
- Chibret
- Copals
- Copal
- cis-Sulindac
- Copal resin
- Resin copal
- cowrie
- Gum copal
- Novo Sundac
- Novo-Sundac
- Nu Sulindac
- Sukurinoru
- Apo Sulin
- Apo-Sulin
- Kulilolel
- Moblilin
- Skanoorin
- Sulindal
- Kenalin
- Clinax
- Reumyl
- Aclin
- Nu-Sulindac
- Clinoril (TN)
- Copal rosin varnish
- Sulindac CRS
- Sulindacum [INN-Latin]
- Sulindaco [INN-Spanish]
- Sulindac (Clinoril)
- Sulindac (Standard)
- C20H17FO3S
- 184SNS8VUH
- MK-231
- Tocris-1707
- Merck Brand of Sulindac
- RefChem:56287
- SULINDAC [USAN]
- UNII-184SNS8VUH
- SULINDAC [INN]
- SULINDAC [JAN]
- MK 231
- SULINDAC [MI]
- AC1LU7GY
- Apotex Brand of Sulindac
- Chemia Brand of Sulindac
- SULINDAC [VANDF]
- Clinoril;Aflodac;Sulreuma
- KendrickBrand of Sulindac
- Prestwick3_000073
- Spectrum5_001024
- CCRIS 3305
- CHEBI:9352
- Lopac-S-8139
- SULINDAC [MART.]
- DTXSID4023624
- CHEMBL15770
- D0Z5IU
- SULINDAC [USP-RS]
- SULINDAC [WHO-DD]
- Sulindac, >=98.0%
- Novopharm Brand of Sulindac
- Nu Pharm Brand of Sulindac
- Nu-Pharm Brand of Sulindac
- SCHEMBL4202
- Sulindac [USAN:BAN:INN:JAN]
- DTXCID703624
- Sulindac (JAN/USP/INN)
- Alphapharm Brand of Sulindac
- MK231
- UNII-M5221THD3M
- Lopac0_001070
- MFCD00599589
- BSPBio_000285
- BSPBio_002890
- MLS001056554
- Sulindac - Bio-X trade mark
- NSC-757344
- SPECTRUM1500556
- EINECS 253-819-2
- Sulindac (JP18/USP/INN)
- MLKXDPUZXIRXEP-MFOYZWKCSA-N
- SULINDAC [ORANGE BOOK]
- BPBio1_000315
- GTPL5425
- orb1310592
- SULINDAC [EP MONOGRAPH]
- (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid
- SCHEMBL29360981
- SULINDAC [USP MONOGRAPH]
- CHEBI:93811
- EINECS 250-893-8
- EINECS 256-402-3
- ERK5-2K15
- HMS501O03
- HY-B0008R
- BRN 2951842
- HLX0201
- M01AB02
- MSK7166
- Sulindac [USAN:INN:BAN:JAN]
- cMAP_000021
- s2007
- GLXC-20079
- HMS1921C11
- HMS2092K15
- HMS2095O07
- HMS2231N24
- HMS3259K06
- HMS3263E22
- HMS3414N11
- HMS3649P19
- HMS3678N09
- HMS3712O07
- HMS3884K18
- HMS5080B15
- Pharmakon1600-01500556
- Sulindac [USAN:USP:INN:BAN:JAN]
- HLX-0201
- HY-B0008
- Sulindac for system suitability CRS
- C20-H17-F-O3-S
- EINECS 232-527-9
- Sulindac 100 microg/mL in Acetonitrile
- Tox21_110270
- Tox21_301418
- Tox21_501070
- BDBM50012899
- BDBM50103504
- CCG-39264
- EBC-11159
- MSK7166-100A
- NCGC00015970-02
- NSC757344
- SBB058181
- Cahill May Roberts Brand of Sulindac
- AKOS015895412
- MSK7166-1000A
- Tox21_110270_1
- CID1548887
- cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid
- CS-0569
- DB00605
- FS27969
- J3.501G
- KS-5153
- LP01070
- Merck Sharp & Dohme Brand of Sulindac
- NC00540
- NSC 757344
- SDCCGSBI-0051040.P005
- CAS-38194-50-2
- IDI1_000601
- NCGC00015970-01
- NCGC00015970-03
- NCGC00015970-04
- NCGC00015970-05
- NCGC00015970-06
- NCGC00015970-07
- NCGC00015970-08
- NCGC00015970-11
- NCGC00025268-01
- NCGC00025268-02
- NCGC00025268-03
- NCGC00094349-01
- NCGC00094349-02
- NCGC00255143-01
- NCGC00261755-01
- NCGC00381714-10
- (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
- BP-30208
- BS166205
- cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
- CPD000326718
- LS-14757
- LS-81610
- SAM002554933
- SMR000326718
- SY075375
- S 8139
- SBI-0051040.P004
- Sulindac, meets USP testing specifications
- AB2000418
- RT-000169
- 2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid
- AB00513800
- B2044
- cis-5-Fluoro-2-methyl-1-[(p-methylsulfiny
- EU-0101070
- NS00006901
- ST24026687
- ST51015123
- Sulindac Solution in Acetonitrile, 100ug/mL
- Sulindac, 98%, a COX inhibitor - 1G 1g
- SW219748-1
- U0099
- Sulindac Solution in Acetonitrile, 1000ug/mL
- 9222-EP2275420A1
- 9222-EP2277565A2
- 9222-EP2277566A2
- 9222-EP2277567A1
- 9222-EP2277568A2
- 9222-EP2277569A2
- 9222-EP2277570A2
- 9222-EP2280008A2
- 9222-EP2281815A1
- 9222-EP2284166A1
- 9222-EP2292280A1
- 9222-EP2295055A2
- 9222-EP2295409A1
- 9222-EP2298764A1
- 9222-EP2298765A1
- 9222-EP2301933A1
- 9222-EP2305640A2
- 9222-EP2305652A2
- 9222-EP2308872A1
- 9222-EP2311453A1
- 9222-EP2311827A1
- 9222-EP2314585A1
- 9222-EP2314590A1
- 9222-EP2316829A1
- C01531
- D00120
- W-5115
- AB00052105-07
- AB00052105_08
- AB00052105_09
- EN300-7363233
- 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-
- Q963093
- SR-01000075237
- A1202576
- SR-01000075237-2
- SR-01000075237-3
- SR-01000075237-5
- SR-01000075237-7
- 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
- BRD-A13946108-001-04-9
- BRD-A13946108-001-08-0
- BRD-A13946108-001-16-3
- BRD-A13946108-001-17-1
- BRD-A13946108-001-18-9
- BRD-A13946108-001-19-7
- SR-01000075237-13
- 32004-68-5
- Sulindac, European Pharmacopoeia (EP) Reference Standard
- (Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
- {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
- 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
- (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
- cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid
- Sulindac, United States Pharmacopeia (USP) Reference Standard
- (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)-benzylidene)-1H-inden-3-yl)acetic acid
- (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
- 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-
- 1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-
- 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid
- 1H-INDENE-3-ACETIC ACID, 5-FLUORO-2-METHYL-1-((4-(METHYLSULFINYL)PHENYL)METHYLENE)-, (1Z)-
- cis-5-fluoro-2-methyl-1-(p-(methylsulfinyl)benzylidene)indene-3-acetic acid
- cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
- TERT-BUTYL N-[(1R)-1-(ETHYLCARBAMOYL)-2-METHYLBUTYL]CARBAMATE
- Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid
- (1Z)-(5-Fluoro-2-methyl-1-(4-((RS)-methylsulfinyl)benzylidene)-lH-inden-3-yl)acetic acid
- (1Z)-5-Fluoro-2-methyl-1-[(4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
- (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
- (1Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]-1H-indene-3-acetic acid
- (S,Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid
- (Z)-2-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic Acid
- (Z)-5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
- (Z)-5-Fluoro-2-methyl-1-[(p-methylsulfinyl)benzylidene]-1H-indene-3-acetic Acid
- (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)-phenyl]methylene]-1H-indene-3-acetic acid
- [5-Fluoro-2-methyl-1-[(Z)-4-methylsulfinylbenzylidene]-1H-indene-3-yl]acetic acid
- {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
- {(1z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-indene-3-yl}acetic acid
- {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
- 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-
- 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (Z)-
- 2-(5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylene}inden-3-yl)acetic acid
- 2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
- 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]-1-indenyl]acetic acid
- 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
- 5-Fluoro-2-methyl-1-[(Z)-p-(methylsulfinyl)benzylidene]-1H-indene-3-acetic acid
- 5-Fluoro-2-methyl-1-[(Z)-p-methylsulfinylbenzylidene]-1H-indene-3-acetic acid
- 5-fluoro-2-methyl-1-[[4-(methylsulphinyl)phenyl]methylene]-1H-indene-3-acetic acid
- (E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
- (Z)-(+-)-5-fluoro-2-methyl-1-[[4-(methylsulphinyl)phenyl]methylene]-1H-indene-3-acetic acid
- [(1E)-5-Fluoro-1-{[4-(methanesulfinyl)phenyl]methylidene}-2-methyl-1H-inden-3-yl]acetic acid
- [(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid
- 1008020-33-4
- 149116-77-8
- 2-((1Z)-5-fluoro-1-((4-methanesulfinylphenyl)methylidene)-2-methyl-1H-inden-3-yl)acetic acid
- 253-819-2
- 49627-22-7
- 9000-14-0
- Copals. Extractives and their physically modified derivatives. It is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes. (Trachylobium or Hymenaea courbaril, Leguminosae)
- Sulindac; (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid; MK-231; Aflodac; Algocetil; Arthrocine; Artribid; Citireuma; Clinoril; Clisundac; Reumofil; Reumyl; Sudac; Sulinol; Sulreuma
- Sulindac|(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid